We are live on ! Find out more
SC

Schulhoff & Co Portfolio holdings

AUM $243M
1-Year Est. Return 17.47%
This Fund
S&P 500
This Quarter Est. Return
+8.26%
1 Year Est. Return
+17.47%
3 Year Est. Return
+42.69%
5 Year Est. Return
+58.83%
10 Year Est. Return
+178.36%
AUM
$240M
AUM Growth
+$17.9M
Cap. Flow
+$568K
Cap. Flow %
0.24%
Top 10 Hldgs %
43.93%
Holding
131
New
5
Increased
34
Reduced
37
Closed
3

Top Buys

Rank Stock Value
1
PYXS icon
Pyxis Oncology
PYXS
+$280K
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$232K
3
JCI icon
Johnson Controls International
JCI
+$202K
4
LAMR icon
Lamar Advertising Co
LAMR
+$198K
5
DEO icon
Diageo
DEO
+$196K

Top Sells

Rank Stock Value
1
EW icon
Edwards Lifesciences
EW
+$264K
2
PFE icon
Pfizer
PFE
+$229K
3
VNDA icon
Vanda Pharmaceuticals
VNDA
+$218K
4
HI
Hillenbrand
HI
+$200K
5
DIS icon
Walt Disney
DIS
+$114K

Sector Composition

Rank Sector Weight
1 Consumer Staples 26.49%
2 Financials 16.59%
3 Industrials 12.75%
4 Healthcare 11.19%
5 Technology 8.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMY icon
51
Bristol-Myers Squibb
BMY
$124B
$1.16M 0.48%
22,414
– –
RYN icon
52
Rayonier
RYN
$6.56B
$1.14M 0.47%
38,942
-260
-0.7% -$7.09K
WMB icon
53
Williams Companies
WMB
$89.7B
$996K 0.42%
17,783
-100
-0.6% -$4.4K
SYY icon
54
Sysco
SYY
$39.1B
$941K 0.39%
12,053
+26
+0.2% +$1.96K
NSC icon
55
Norfolk Southern
NSC
$76.4B
$906K 0.38%
3,645
-10
-0.3% -$2.4K
BNY
56
Bank of New York Mellon
BNY
$108B
$887K 0.37%
12,338
+4
+0% +$263
ED icon
57
Consolidated Edison
ED
$41.4B
$876K 0.37%
8,416
– –
MEDP icon
58
Medpace
MEDP
$15.4B
$868K 0.36%
2,600
+270
+12% +$103K
HUBB icon
59
Hubbell
HUBB
$25.8B
$852K 0.36%
1,988
– –
DD icon
60
DuPont de Nemours
DD
$18.3B
$841K 0.35%
7,522
-102
-1% -$10.4K
NEE icon
61
NextEra Energy
NEE
$185B
$837K 0.35%
9,897
– –
HSY icon
62
Hershey
HSY
$34.8B
$802K 0.33%
4,181
+550
+15% +$107K
TJX icon
63
TJX Companies
TJX
$171B
$791K 0.33%
6,728
+6
+0.1% +$688
NVS icon
64
Novartis
NVS
$293B
$714K 0.3%
6,210
– –
INTC icon
65
Intel
INTC
$478B
$685K 0.29%
29,215
-2,587
-8% -$64.6K
SHEL icon
66
Shell
SHEL
$242B
$684K 0.29%
10,367
+275
+3% +$19.5K
DIS icon
67
Walt Disney
DIS
$170B
$678K 0.28%
7,053
-1,238
-15% -$114K
WY icon
68
Weyerhaeuser
WY
$17.7B
$635K 0.27%
18,755
-500
-3% -$15.4K
NEM icon
69
Newmont
NEM
$95.8B
$633K 0.26%
11,850
– –
OGE icon
70
OGE Energy
OGE
$10.1B
$608K 0.25%
14,825
– –
SPG icon
71
Simon Property Group
SPG
$74.2B
$569K 0.24%
3,366
– –
CL icon
72
Colgate-Palmolive
CL
$74.4B
$554K 0.23%
5,334
– –
CAT icon
73
Caterpillar
CAT
$405B
$548K 0.23%
1,400
– –
SO icon
74
Southern Company
SO
$107B
$541K 0.23%
6,000
– –
DOW icon
75
Dow Inc
DOW
$21.6B
$533K 0.22%
9,750
– –
1 2
3
4 5

Similar funds

HCM
Hutner Capital Management Manchester, Vermont $243M AUM 10.01% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
SC
Solstein Capital Menlo Park, California $244M AUM 29.05% 1-Year Est. Return
YP
YANKCOM Partnership Yankton, South Dakota $243M AUM 21.59% 1-Year Est. Return
HBS
Howard Bailey Securities Fort Wayne, Indiana $243M AUM 13.36% 1-Year Est. Return
QHA
Quarry Hill Advisors St Paul, Minnesota $243M AUM 24.02% 1-Year Est. Return
GIM
GE Investment Management Norwalk, Connecticut $244M AUM 41.62% 1-Year Est. Return
BB
Burford Brothers Dallas, Texas $244M AUM 24.94% 1-Year Est. Return

Schulhoff & Co's Q3 2024 Portfolio in Review

As of Q3 2024, Schulhoff & Co held 131 positions worth $240M, up 8.1% from $222M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Schulhoff & Co's Q3 2024 filing shows 5 new, 34 increased, 37 reduced and 3 closed positions. Its largest new stake was Johnson Controls International: 2,873 shares worth $223K. The largest sale was Edwards Lifesciences, an estimated $264K.

By sector, the portfolio is most concentrated in Consumer Staples at 26% of assets, down from 27% a quarter earlier, followed by Financials and Industrials.

  • Schulhoff & Co's largest Q3 2024 buy was Johnson Controls International: 2,873 shares worth $223K.
  • Schulhoff & Co added most to Pyxis Oncology in Q3 2024, an estimated $280K increase.
  • Schulhoff & Co's biggest Q3 2024 reduction was Pfizer, cutting an estimated $229K.
  • Schulhoff & Co fully exited Edwards Lifesciences in Q3 2024, selling an estimated $264K.
  • Schulhoff & Co's ten largest holdings make up 44% of its $240M portfolio in Q3 2024.
  • Schulhoff & Co opened 5 new positions and closed 3 in Q3 2024.
  • Schulhoff & Co's portfolio value rose 8.1% quarter-over-quarter to $240M.

Based on Schulhoff & Co's 13F filing for Q3 2024, filed 6 Nov 2024.